In an exclusive video interview with Diagnostic Imaging, Josh Cooper, vice president of congressional affairs for the American College of Radiology (ACR), and Thomas Hoffman, vice president of legal for the ACR, discuss the ACR’s lawsuit over the IDR process of the No Surprises Act and the potential impact of the law on reimbursement and patient access to care.
The No Surprises Act, which went into effect on January 1, is intended to curtail surprise medical bills for patients who receive emergency care at out-of-network facilities and non-emergency care provided at in-network facilities. However, a key aspect of the law’s independent dispute resolution (IDR) process, as noted in the interim final rule for the legislation, has drawn legal challenges from medical organizations including the American College of Radiology (ACR).
According to the ACR, the IDR process, which providers can use to negotiate reimbursement amounts from insurers, was intended to consider several factors, including patient complexity, scope of services and qualified payment amount (QPA). However, the interim final rule for the legislation establishes the QPA, set by insurers, as the primary determining factor for the IDR process, notes the ACR. The ACR, along with the American College of Emergency Physicians and the American Society of Anesthesiologists, recently filed a lawsuit against the United States Department of Health and Human Services (HHS), challenging this provision of the IDR process of the No Surprises Act.
In a recent video interview, Thomas Hoffman, JD, CAE, vice president of legal for the American College of Radiology (ACR), and Josh Cooper, vice president of congressional affairs for the ACR, discussed the lawsuit and the potential impact of the current law’s IDR process upon reimbursement for radiologists and access to timely imaging for patients. Watch below.
Seven Takeaways from New CT and MRI Guidelines for Ovarian Cancer Staging
January 20th 2025In an update of previous guidelines from the European Society of Urogenital Radiology published in 2010, a 21-expert panel offered consensus recommendations on the utility of CT, MRI and PET-CT in the staging and follow-up imaging for patients with ovarian cancer.
The Reading Room Podcast: Emerging Trends in the Radiology Workforce
February 11th 2022Richard Duszak, MD, and Mina Makary, MD, discuss a number of issues, ranging from demographic trends and NPRPs to physician burnout and medical student recruitment, that figure to impact the radiology workforce now and in the near future.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.